PharmaReports: Cardiovascular Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports relating to all aspects of cardiovascular disease are included here with the exception of those relating to neurodegenerative components of stroke. Reports with a focus on atherosclerosis are also included here
Showing results 101 - 150 of 153
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- The Future of Metabolic Disorder Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities
- Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015
- Angina Pectoris - Drug Pipeline Analysis and Market Forecasts to 2016
- Regenerative Medicine Markets
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017
- Genetic Testing Global Market Briefing to 2016
- Interventional Cardiology Devices Global Market Briefing to 2016
- US Pharmaceutical Market Outlook 2011-2021
- Cardiovascular Devices Market to 2016 - Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices to be the Key Revenue Generators
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
- Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
- Future Directions in Regenerative Medicine
- The Future of In Vitro and In Vivo Diagnostic Integration
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- Pharmaceutical Key Trends 2011 – Biosimilar Market Overview: Biosimilar uptake set to accelerate
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value
- Gleevec (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Adcirca (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Remodulin (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Tyvaso (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Macitentan (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Selexipag (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Riociguat (Pulmonary Arterial Hypertension) - Analysis Forecasts to 2020
- Ventavis (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2017
- Letairis/Volibris (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Emerging Countries Cardiovascular Devices Market to 2017 - Increasing Incidence of Cardiovascular Diseases and Lifestyle Disorders to Drive the Market
- Revatio (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Tracleer (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Veletri (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Critical Limb Ischemia (CLI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development